Clinical illness as a marker for initiation of HIV antiretroviral therapy in a rural setting, Rakai, Uganda

Int J STD AIDS. 2006 Feb;17(2):116-20. doi: 10.1258/095646206775455766.

Abstract

The aim of this study is to assess whether HIV-related illness and World Health Organization (WHO) clinical stage can be used to guide initiation of antiretroviral therapy (ART) in rural Rakai District, Uganda. A retrospective cohort analysis of 910 HIV-seroprevalent individuals randomly sampled from a community cohort was conducted. The associations between HIV-related clinical illness and HIV viral loads >55,000 copies/mL and death were evaluated as a guide for initiation of ART. Reporting one or more HIV-related illnesses was associated with high specificity for identifying HIV viral load >55,000 copies/mL and predicting death within 30 months. There were more deaths in those with one symptom at baseline (16.3%) and two or more symptoms (25.0%) than in those reporting no symptoms (9.6%; P = 0.001).HIV-related illness and WHO stage predicted disease progression. The specificity of clinical illness to predict viral load >55,000 copies/mL was high and could be used to rule in HIV disease requiring ART.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections / epidemiology*
  • Algorithms
  • Anti-HIV Agents / economics
  • Anti-HIV Agents / therapeutic use*
  • Cohort Studies
  • Disease Progression
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / physiopathology
  • HIV Infections / virology
  • HIV-1
  • Humans
  • Retrospective Studies
  • Rural Health*
  • Uganda
  • Viral Load

Substances

  • Anti-HIV Agents